Product Images Trisenox

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Trisenox NDC 63459-601 by Cephalon, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image 1

image 1

image 2

image 2

The text is a chart showing survival rates for newly-diagnosed acute promyelocytic leukemia (APL) patients treated with ATRA-arsenic trioxide and ATRA-chemotherapy over a period of 6 months. The x-axis represents months since diagnosis, and the y-axis represents the percentage of patients who are event-free (i.e., have not experienced disease recurrence or death). The chart shows a higher event-free survival rate for those receiving ATRA-arsenic trioxide compared to those receiving ATRA-chemotherapy. The chart also includes a table showing the number of patients at risk for each treatment group at various time intervals.*

image 3

image 3

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.